BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2757603)

  • 1. A qualitative and quantitative assay of dihydrofolate reductase in carrot cells resistant to methotrexate.
    Nano R; Cella R; Rezzani R; Rodella L; Gerzeli G
    Basic Appl Histochem; 1989; 33(2):81-92. PubMed ID: 2757603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective expression of methotrexate-resistant dihydrofolate reductase (DHFR) activity in mice transduced with DHFR retrovirus and administered methotrexate.
    Vinh DB; McIvor RS
    J Pharmacol Exp Ther; 1993 Nov; 267(2):989-96. PubMed ID: 8246174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanisms of development of resistance to methotrexate in choriocarcinoma cells].
    Sakai K
    Hokkaido Igaku Zasshi; 1986 Sep; 61(5):649-61. PubMed ID: 3781466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of methotrexate on dihydrofolate reductase activity in methotrexate-resistant human KB cells.
    Domin BA; Grill SP; Bastow KF; Cheng YC
    Mol Pharmacol; 1982 Mar; 21(2):478-82. PubMed ID: 7099148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Localization of dihydrofolate reductase amplified genes in Chinese hamster cells resistant to methotrexate].
    Mukhamedkhanova FS; Kuznetsova NN; Nuridzhaniants SS; Abdurkarimov AA
    Genetika; 1987 Sep; 23(9):1588-94. PubMed ID: 3692154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methotrexate preconditioning allows sufficient engraftment to confer drug resistance in mice transplanted with marrow expressing drug-resistant dihydrofolate reductase activity.
    Belur LR; James RI; May C; Diers MD; Swanson D; Gunther R; McIvor RS
    J Pharmacol Exp Ther; 2005 Aug; 314(2):668-74. PubMed ID: 15857949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydrofolate reductase binding and cellular uptake of nonpolyglutamatable antifolates: correlates of cytotoxicity toward methotrexate-sensitive and -resistant human head and neck squamous carcinoma cells.
    Chen G; Wright JE; Rosowsky A
    Mol Pharmacol; 1995 Oct; 48(4):758-65. PubMed ID: 7476904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H; Niethammer D; Jackson RC
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flow cytometric analysis of mammalian glial cultures treated with methotrexate.
    Serrano EE; Schimke RT
    Glia; 1990; 3(6):539-49. PubMed ID: 2148556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic heterogeneity in cultured human head and neck squamous cell carcinoma lines with low-level methotrexate resistance.
    Rosowsky A; Wright JE; Cucchi CA; Lippke JA; Tantravahi R; Ervin TJ; Frei E
    Cancer Res; 1985 Dec; 45(12 Pt 1):6205-12. PubMed ID: 2415240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mechanisms of resistance to antifolates, a review.
    Banerjee D; Ercikan-Abali E; Waltham M; Schnieders B; Hochhauser D; Li WW; Fan J; Gorlick R; Goker E; Bertino JR
    Acta Biochim Pol; 1995; 42(4):457-64. PubMed ID: 8852336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment of dihydrofolate reductase-increased human cell lines and relationship between dihydrofolate reductase levels and gene copy.
    Domin BA; Grill SP; Cheng Y
    Cancer Res; 1983 May; 43(5):2155-8. PubMed ID: 6831441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of methotrexate resistance and dihydrofolate reductase gene amplification by c-myc.
    Denis N; Kitzis A; Kruh J; Dautry F; Corcos D
    Oncogene; 1991 Aug; 6(8):1453-7. PubMed ID: 1886715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic changes in methotrexate-resistant mosquito cells.
    Shotkoski FA; Fallon AM
    Arch Insect Biochem Physiol; 1990; 15(2):79-92. PubMed ID: 1724612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-resistant dihydrofolate reductases: generation, expression and therapeutic application.
    McIvor RS
    Bone Marrow Transplant; 1996 Dec; 18 Suppl 3():S50-4. PubMed ID: 8971409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increasing methotrexate resistance by combination of active-site mutations in human dihydrofolate reductase.
    Volpato JP; Fossati E; Pelletier JN
    J Mol Biol; 2007 Oct; 373(3):599-611. PubMed ID: 17868689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective killing of methotrexate-resistant cells carrying amplified dihydrofolate reductase genes.
    Urlaub G; Landzberg M; Chasin LA
    Cancer Res; 1981 May; 41(5):1594-601. PubMed ID: 7194140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of methotrexate resistance conferred by a mutated dihydrofolate reductase (DHFR) cDNA in two different retroviral vectors.
    Takebe N; Nakahara S; Zhao SC; Adhikari D; Ural AU; Iwamoto M; Banerjee D; Bertino JR
    Cancer Gene Ther; 2000 Jun; 7(6):910-9. PubMed ID: 10880023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry of dihydrofolate reductase in methotrexate-sensitive and -resistant human cell lines by flow cytometry: a comparison with the cytochemical tetrazolium salt method.
    Nano R; Gerzeli G; Morandi C; Arisi C
    Acta Histochem; 1992; 93(1):290-7. PubMed ID: 1529671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of dihydrofolate reductase activity in intact leukemia cells and squamous cell carcinoma.
    FitzGerald GB; Wick MM
    Anticancer Drug Des; 1989 Jun; 4(1):79-87. PubMed ID: 2757754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.